Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anselm K Gitt

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Herz|December 7, 2005
[Actual clinical practice of guideline-recommended therapy of acute ST elevation myocardial infarction]Harm Wienbergen, Anselm K Gitt, Jochen Senges
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 4, 2010
Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in GermanyAnselm K Gitt, Claus Jünger, Wenefrieda Smolka, et al.
Diabetes & Vascular Disease Research|November 15, 2015
Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitusDiethelm Tschöpe, Peter Bramlage, Steffen Schneider, et al.
Cardiovascular Diabetology|February 4, 2015
A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapyAnselm K Gitt, Peter Bramlage, Steffen Schneider, et al.
Wiener Klinische Wochenschrift|September 28, 2011
Persistent dyslipidemia in Austrian patients treated with statins for primary and secondary prevention of atherosclerotic events - Results of the DYSlipidemia International Study (DYSIS)Heinz Drexel, Francois Chazelle, Christiane Fauer, et al.
Herz|May 8, 2023
Management of the COVID-19 pandemic in Rhineland-Palatinate hospitals of all levels of care : Results of the COVID-19 Registry RLPAnselm K Gitt, Martin Horack, Steffen Schneider, et al.
Zeitschrift Fur Kardiologie|March 19, 2003
Clinical practice of primary angioplasty for the treatment of acute myocardial infarction in Germany: results from the MITRA and MIR registriesRalf Zahn, Rudolf Schiele, Steffen Schneider, et al.
BMC Cardiovascular Disorders|November 21, 2014
Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-upPeter Bramlage, Anselm K Gitt, Steffen Schneider, et al.
Cardiovascular Diabetology|January 24, 2018
Individualised treatment targets in patients with type-2 diabetes and hypertensionRoland E Schmieder, Diethelm Tschöpe, Cornelia Koch, et al.
Cardiovascular Diabetology|October 9, 2012
Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemiaPeter Bramlage, Anselm K Gitt, Christiane Binz, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Herz|December 7, 2005
[Actual clinical practice of guideline-recommended therapy of acute ST elevation myocardial infarction]Harm Wienbergen, Anselm K Gitt, Jochen Senges
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 4, 2010
Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in GermanyAnselm K Gitt, Claus Jünger, Wenefrieda Smolka, et al.
Diabetes & Vascular Disease Research|November 15, 2015
Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitusDiethelm Tschöpe, Peter Bramlage, Steffen Schneider, et al.
Cardiovascular Diabetology|February 4, 2015
A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapyAnselm K Gitt, Peter Bramlage, Steffen Schneider, et al.
Wiener Klinische Wochenschrift|September 28, 2011
Persistent dyslipidemia in Austrian patients treated with statins for primary and secondary prevention of atherosclerotic events - Results of the DYSlipidemia International Study (DYSIS)Heinz Drexel, Francois Chazelle, Christiane Fauer, et al.
Herz|May 8, 2023
Management of the COVID-19 pandemic in Rhineland-Palatinate hospitals of all levels of care : Results of the COVID-19 Registry RLPAnselm K Gitt, Martin Horack, Steffen Schneider, et al.
Zeitschrift Fur Kardiologie|March 19, 2003
Clinical practice of primary angioplasty for the treatment of acute myocardial infarction in Germany: results from the MITRA and MIR registriesRalf Zahn, Rudolf Schiele, Steffen Schneider, et al.
BMC Cardiovascular Disorders|November 21, 2014
Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-upPeter Bramlage, Anselm K Gitt, Steffen Schneider, et al.
Cardiovascular Diabetology|January 24, 2018
Individualised treatment targets in patients with type-2 diabetes and hypertensionRoland E Schmieder, Diethelm Tschöpe, Cornelia Koch, et al.
Cardiovascular Diabetology|October 9, 2012
Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemiaPeter Bramlage, Anselm K Gitt, Christiane Binz, et al.
Pageof 10